Dr David Johnson selects his 10 highest-impact publications from 2025, which define new management standards across a broad spectrum of diseases.

Long-term follow-up of Taiwanese children with chronic hepatitis B virus (HBV) infection showed that 3.29% had HBV surface antigen (HBsAg) seroconversion after antiviral treatment while another 3.86% ...

New research shows resilience partially offsets financial toxicity and improves quality of life in patients with primary ...

Nebokitug is a lab-engineered antibody that targets a molecule called CCL24, a signaling protein known to drive inflammation ...

SMC officials announced the addition of Gastroenterologist Dr. Ryan Burkholder, who will provide monthly clinics, as well as ...

The 2024 report on China’s gastroenterology and digestive endoscopy, based on national databases, highlights increased early cancer detection, optimized care for priority diseases, and enhanced ...

Highlighting innovation and advanced care, Executive Director and Chief Executive Officer, All India Institute of Medical Sciences, Jammu, Prof. (Dr.) Shakti Kumar Gupta stated that AIIMS Jammu houses ...

A multicenter study led by UC Davis Health has tested a new treatment designed to improve care for people with a rare liver ...

Study identifies promising new treatment effective against rare liver disease A new experimental therapy may finally offer ...

Discover the surprising health benefits of farting, from improving gut health and reducing bloating to signaling potential ...

Retrospective studies link proton pump inhibitors to multiple conditions; however, careful analysis shows that causality ...

Researchers have reported encouraging results from a clinical trial of a new monoclonal antibody therapy for primary ...